# Codoxo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/codoxo

- Industry: Healthcare IT
- Headquarters: Duluth, US
- Website: www.codoxo.com
- Total disclosed funding: $62M
- Latest round: Series C (Dec 17, 2025)
- Investors on record: 12

## About

Codoxo, Inc., based in Atlanta, US, specializes in providing a Unified Cost Containment Platform utilizing generative AI to streamline healthcare claims processes, enhancing operational efficiency for healthcare stakeholders. Founded in 2016 by Musheer Ahmed, Codoxo, Inc. operates primarily in the healthcare sector, offering advanced solutions for claims management. In December 2025, Codoxo, Inc. raised USD 35 million in series C funding led by new investor CVS Health Ventures, with participation from another investor Echo Health Ventures. Returning investors Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures, QED Investors, and other unspecified investors also participated in the round. Codoxo specializes in a Unified Cost Containment Platform that leverages generative AI and advanced automation to enhance the healthcare claims submission process. This platform facilitates accurate claims submissions, significantly reducing denials, appeals, and resubmissions. Key functionalities include automated provider education for submission accuracy, streamlined audit detection workflows, and pre-payment accuracy assessments. Codoxo serves a diverse client base, impacting over 80 million lives and extending its reach beyond the US healthcare market to various global healthcare systems.Codoxo's revenue model is primarily based on subscription agreements with healthcare payer clients, engaging them through annual contracts or long-term partnerships. Their flagship products, such as ClaimPilot, enable healthcare organizations to optimize operations and improve claims processing accuracy. Clients typically realize significant cost savings of over USD 60 per member annually, reflecting the operational efficiencies Codoxo’s solutions provide. The company plans to utilize the December 2025 funding to boost the expansion and development of its payment integrity solutions that leverage generative AI technology.

## Funding rounds

- Series C, Dec 17, 2025, $35M — QED Investors, Wipro Ventures, Echo Health Ventures, Brewer Lane Ventures, CVS Health Ventures, 111 West Capital, 450 Ventures, Sands Capital Alternatives
- Series B, Dec 13, 2021, $20M — QED Investors, GRA Venture Fund, Spider Capital, Sands Capital Alternatives, Brewer Lane Ventures, 111 West Capital
- Series A, Jul 2, 2020, $7M — QED Investors, GRA Venture Fund, Mosley Ventures, Spider Capital, Tech Square Labs, Brewer Lane Ventures

## Investors

- QED Investors (https://capitalatlas.ai/funds/qed-investors) — Series A, Series B, Series C
- GRA Venture Fund (https://capitalatlas.ai/funds/gra-venture-fund) — Series A, Series B
- Mosley Ventures (https://capitalatlas.ai/funds/mosley-ventures) — Series A
- Spider Capital (https://capitalatlas.ai/funds/spider-capital) — Series A, Series B
- Tech Square Labs (https://capitalatlas.ai/funds/tech-square-labs) — Series A
- Brewer Lane Ventures (https://capitalatlas.ai/funds/brewer-lane-ventures) — Series A, Series B, Series C
- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series B, Series C
- 111 West Capital (https://capitalatlas.ai/funds/111-west-capital) — Series B, Series C
- Wipro Ventures (https://capitalatlas.ai/funds/wipro-ventures) — Series C
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series C
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series C
- 450 Ventures — Series C